Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T19:17:06.922Z.
Consensus retrieved: 2026-10-06T12:37:16.302Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T19:17:06.922Z.
Quote observation: 2026-10-06T19:14:54.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4b900084dfad819c514917b73a3910c9d2e92354b8183d11bfa5ab73513aed11
Forward PE Ratio (N/A) = Dated Quote Price ($3.21) / Consensus Forward EPS ($-3.66)
FORWARD PE RATIO
N/A
SeaStar Medical Holding Corporation
Market Cap
$9.11M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| SeaStar Medical Holding Corporation (ICU) | $9.11M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $8.95M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.30M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.65M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.72M | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.82M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.82M | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.35M | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.26M | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.23M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $3.21, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-3.66 | $-3.68 – $-3.64 | 1 | n/m |
| 2027-12-31 | $-2.09 | $-2.10 – $-2.08 | 1 | n/m |
| 2028-12-31 | $-0.76 | $-0.76 – $-0.76 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
